Stock Code
603707.SH
ABOUT
>
Company profile
Enterprise Culture
Early Warning System
PRODUCTS
>
Product List
Commercialized Products
INNOVATION
>
Small Molecule Pharmaceuticals
Macromolecule pharmaceuticals
Global Regulatory Registration Support
Commercial cooperation
MEDIA
>
News in NKF
Industry dynamics
CONTACT
CH / EN
Global market commercialization cooperation
Home
>
INNOVATION
>
Commercial cooperation
Global Market Commercialization Platform
Annual sales growth of over 400% from 2016 to 2019
Detached International Sales Team
The US company Meitheal Pharmaceuticals was founded in December, 2016 and was acquired by Kingfriend in 2019 and formed scale sales in 2020.
Meitheal Today
Chicago-based injectable generic drug distribution company
Experienced leadership,
With nearly 150 years of experience in the U.S. generics industry
Approximately 70 employees,
involved in clinical, registration, marketing and sales.
Stable equity structure and positive growth projections
Grouping a hospital sales team in 2019
Diversified product range:
Products are involved in many different clinical departments
With our Partner Nanjing King-Friend(NKF), who are approved by FDA, we are committed to producing high quality products.
Seeking further opportunities in the biologics and biosimilars market
Talk to our researchers about your project
Click to enter
bob手机客户端网页
|
HTH华体会网页版(中国)股份有限公司
|
开运体育篮球官网(中国)股份有限公司
|
NBA下注官网
|
英超联赛下注平台
|
华体电竞官网(中国)有限公司
|
五大联赛下注app官网
|
华体体育app官网(中国)股份有限公司
|
爱游戏体育客户端官网(中国)股份有限公司
|